Our Company

Equilibria Medical Scientific Services (ELMS) is an independent medical affairs consultancy born from extensive industry expertise and a passion for advancing healthcare solutions.

ELMS was established to bridge the gap between clinical excellence and commercial success in the healthcare industry. Drawing on our founder's extensive experience in critical care nursing, regional account management, and medical scientific liaison roles, we offer a unique blend of clinical, commercial, and medical affairs expertise.

Our company is built on the principle of equilibrium – balancing innovation with wisdom, science with practicality, and commercial objectives with patient outcomes. This balanced approach enables us to deliver exceptional value to our partners across the healthcare ecosystem.

Based in the UK and officially registered as a business, ELMS serves clients across the UK, Ireland, and Nordic countries, with a growing presence throughout Europe.

Medical Professional
Digital Healthcare

Our Mission

At ELMS, our mission is to advance healthcare delivery through strategic medical affairs consulting, evidence-based implementation, and innovative digital solutions. We are committed to improving patient outcomes by bridging the gap between clinical excellence and practical implementation.

Our Vision

We envision a healthcare ecosystem where advanced therapies and technologies are optimally implemented, where clinical teams are empowered with the right knowledge and tools, and where patients receive the best possible care through evidence-based practices.

Our Values

Excellence, Innovation, Integrity, Collaboration, and Patient-Centricity guide everything we do at ELMS.

Our Founder

Meet Daniel Roberts, the driving force behind ELMS

Daniel Roberts

Daniel Roberts

Daniel Roberts is the founder and Managing Director of ELMS, bringing over 14 years of critical care nursing experience and extensive medical affairs leadership to the company.

Prior to establishing ELMS, Daniel served as Principal Medical Liaison with Baxter Healthcare, specialising in Acute Kidney Care Therapies across the UK, Ireland, and Nordic cluster. His career spans Critical Care Nursing, Regional Account Management, and Medical Scientific Liaison roles, providing him with a unique blend of clinical, commercial, and medical affairs expertise.

Daniel holds a BSc (Hons) in Nursing Practice from the University of Manchester, is Association of the British Pharmaceutical Industry (ABPI) qualified, and has Leadership and Management ILM (Level 5) qualification.

Throughout his career, Daniel has led numerous medical initiatives, including pre-launch business strategy for Acute Kidney Injury biomarkers, Western Europe medical championship for Extracorporeal Carbon Dioxide Removal (ECCO2R), and the establishment of the Baxter Virtual Extracorporeal Organ Support symposiums (VECOS).

His passion for advancing healthcare solutions and bridging clinical excellence with commercial success led him to establish ELMS, where he continues to drive innovation in medical affairs consulting.

Our Expertise

ELMS brings specialised expertise in various areas of healthcare and medical affairs

Critical Care Specialisation

Deep expertise in ECCO2R applications, CRRT, blood purification, acute kidney care, therapeutic plasma exchange, and neurological critical care.

Medical Affairs Leadership

Extensive experience in leading medical initiatives, developing educational programmes, and managing key opinion leader relationships.

Strategic Implementation

Proven track record in developing and implementing protocols, driving therapy utilisation, and creating standardised documentation frameworks.

Health Economics

Expertise in developing health economic models, demonstrating value, and supporting market access strategies.

Educational Excellence

Skilled in creating and delivering high-impact educational programmes for healthcare professionals, both in-person and virtually.

International Market Knowledge

Understanding of different healthcare systems across Europe, with experience adapting strategies for diverse healthcare environments.

Our Journey

The key milestones in the development of ELMS

2020

Provided critical education supporting patients receiving renal replacement care during the COVID-19 pandemic.

2021

Established and led the Baxter Virtual Extracorporeal Organ Support symposiums (VECOS).

2022

Served as Western Europe Medical champion for Extracorporeal Carbon Dioxide Removal (ECCO2R).

2023

Daniel Roberts appointed as Principal Medical Liaison at Baxter Healthcare, covering UK, Ireland, and Nordic cluster.

2023

Led pre-launch business strategy for Acute Kidney Injury biomarkers (CCL14) across the UK.

2025

Founding of Equilibria Medical Scientific Services (ELMS) as an independent medical affairs consultancy.

Ready to Work With Us?

Let's discuss how ELMS can support your medical affairs initiatives and contribute to advancing healthcare solutions.

Contact Us